Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE
Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE
Liu Xin
Opinion

Opinion

Liu Xin

Is China profiteering from vaccine deals? That’s just an absurd American claim

  • The recent global vaccine alliance deals signed with Chinese companies has some US politicians and pundits crying foul
  • It’s bad enough to allege that a Chinese ‘scheme’ aims to profiteer from a pandemic. It’s worse to stoke fear that China is pocketing US taxpayers’ money

Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE
Sri Lankan Army Medical Corps personnel give people the Sinopharm Covid-19 vaccine in a public park in Colombo, Sri Lanka, on July 5. Gavi, the global vaccine alliance, has signed purchase agreements for 11 vaccines, including China’s Sinopharm and Sinovac. Photo: EPA-EFE
READ FULL ARTICLE